The ATRIA Risk Scheme to Predict Warfarin-Associated Hemorrhage: Not Ready for Clinical Use
- 10 January 2012
- journal article
- other
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 59 (2), 194-195
- https://doi.org/10.1016/j.jacc.2011.08.071
Abstract
No abstract availableFunding Information
- AstraZeneca
- Boehringer Ingelheim
This publication has 4 references indexed in Scilit:
- A New Risk Scheme to Predict Warfarin-Associated HemorrhageJournal of the American College of Cardiology, 2011
- Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on ThrombosisEP Europace, 2011
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial FibrillationChest, 2010
- Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyAnnals of Internal Medicine, 1999